Cytokinetics
CYTK
CYTK
122 hedge funds and large institutions have $380M invested in Cytokinetics in 2018 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 46 increasing their positions, 34 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
122
Holders Change
-4
Holders Change %
-3.17%
% of All Funds
2.79%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
14
Increased
46
Reduced
34
Closed
17
Calls
$917K
Puts
$875K
Net Calls
+$42K
Net Calls Change
+$182K
Top Buyers
Top Sellers
| 1 |
BI
1
BVF Inc
San Francisco,
California
|
$51.1M |
| 2 |
2
Millennium Management
New York
|
$2.26M |
| 3 |
3
Goldman Sachs
New York
|
$1.56M |
| 4 |
PA
4
Pinnacle Associates
New York
|
$6.4M |
| 5 |
5
Allianz Asset Management
Munich,
Germany
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BFM
126
Boothbay Fund Management
New York
| – | -$157K | -18,928 | Closed |
|
127
AQR Capital Management
Greenwich,
Connecticut
| – | -$126K | -15,186 | Closed |
|
128
Los Angeles Capital Management
Los Angeles,
California
| – | -$92K | -11,059 | Closed |
|
|
AIM
129
Assured Investment Management
New York
| – | -$49K | -5,886 | Closed |
|
130
Simplex Trading
Chicago,
Illinois
| – | -$41K | -4,964 | Closed |
|
131
Russell Investments Group
London,
United Kingdom
| – | -$17K | -2,000 | Closed |
|
|
STA
132
Summit Trail Advisors
New York
| – | -$15K | -1,770 | Closed |
|